Protective host defense against disseminated candidiasis is impaired in mice expressing human interleukin-37. 2014

Frank L van de Veerdonk, and Mark S Gresnigt, and Marije Oosting, and Jos W M van der Meer, and Leo A B Joosten, and Mihai G Netea, and Charles A Dinarello
Department of Medicine, University of Colorado Denver Denver, CO, USA ; Department of Medicine, Radboud University Nijmegen Medical Center Nijmegen, Netherlands ; Radboud Center for Infection Nijmegen, Netherlands.

The effect of the anti-inflammatory cytokine interleukin-37 (IL-37) on host defense against Candida infections remains unknown. We assessed the role of IL-37 in a murine model of disseminated candidiasis using mice transgenic for human IL-37 (hIL-37Tg). Upon exposure to Candida albicans pseudohyphae, macrophages from hIL-37Tg mice release 39% less TNFα compared to cells from wild-type (WT) mice (p = 0.01). In vivo, hIL-37Tg mice displayed a decreased capacity to recruit neutrophils to the site of infection. These defects were associated with increased mortality and organ fungal growth in hIL-37Tg compared to WT mice. We conclude that IL-37 interferes with the innate protective anti-Candida host response by reducing the production of proinflammatory cytokines and suppressing neutrophil recruitment in response to Candida, resulting in an increased susceptibility to disseminated candidiasis.

UI MeSH Term Description Entries

Related Publications

Frank L van de Veerdonk, and Mark S Gresnigt, and Marije Oosting, and Jos W M van der Meer, and Leo A B Joosten, and Mihai G Netea, and Charles A Dinarello
May 1997, Infection and immunity,
Frank L van de Veerdonk, and Mark S Gresnigt, and Marije Oosting, and Jos W M van der Meer, and Leo A B Joosten, and Mihai G Netea, and Charles A Dinarello
May 2010, Infection and immunity,
Frank L van de Veerdonk, and Mark S Gresnigt, and Marije Oosting, and Jos W M van der Meer, and Leo A B Joosten, and Mihai G Netea, and Charles A Dinarello
July 1978, The Journal of infectious diseases,
Frank L van de Veerdonk, and Mark S Gresnigt, and Marije Oosting, and Jos W M van der Meer, and Leo A B Joosten, and Mihai G Netea, and Charles A Dinarello
August 1996, The Journal of infectious diseases,
Frank L van de Veerdonk, and Mark S Gresnigt, and Marije Oosting, and Jos W M van der Meer, and Leo A B Joosten, and Mihai G Netea, and Charles A Dinarello
April 2016, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
Frank L van de Veerdonk, and Mark S Gresnigt, and Marije Oosting, and Jos W M van der Meer, and Leo A B Joosten, and Mihai G Netea, and Charles A Dinarello
January 2008, FEMS immunology and medical microbiology,
Frank L van de Veerdonk, and Mark S Gresnigt, and Marije Oosting, and Jos W M van der Meer, and Leo A B Joosten, and Mihai G Netea, and Charles A Dinarello
May 2006, The Journal of infectious diseases,
Frank L van de Veerdonk, and Mark S Gresnigt, and Marije Oosting, and Jos W M van der Meer, and Leo A B Joosten, and Mihai G Netea, and Charles A Dinarello
February 2005, Microbes and infection,
Frank L van de Veerdonk, and Mark S Gresnigt, and Marije Oosting, and Jos W M van der Meer, and Leo A B Joosten, and Mihai G Netea, and Charles A Dinarello
June 2002, Infection and immunity,
Frank L van de Veerdonk, and Mark S Gresnigt, and Marije Oosting, and Jos W M van der Meer, and Leo A B Joosten, and Mihai G Netea, and Charles A Dinarello
April 2012, Cytokine,
Copied contents to your clipboard!